National Health Investors, Inc. $NHI Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC increased its position in shares of National Health Investors, Inc. (NYSE:NHI) by 20.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 75,426 shares of the real estate investment trust’s stock after buying an additional 12,947 shares during the quarter. Hsbc Holdings PLC’s holdings in National Health Investors were worth $5,760,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Renaissance Group LLC lifted its stake in National Health Investors by 3.8% in the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock worth $245,000 after acquiring an additional 117 shares in the last quarter. GAMMA Investing LLC boosted its position in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 136 shares during the period. Captrust Financial Advisors grew its stake in National Health Investors by 1.7% during the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock valued at $680,000 after acquiring an additional 146 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in National Health Investors by 0.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 24,603 shares of the real estate investment trust’s stock valued at $1,725,000 after acquiring an additional 200 shares in the last quarter. Finally, Mackenzie Financial Corp increased its holdings in shares of National Health Investors by 6.7% in the 3rd quarter. Mackenzie Financial Corp now owns 3,201 shares of the real estate investment trust’s stock valued at $254,000 after purchasing an additional 200 shares during the period. 62.51% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Robert A. Mccabe, Jr. acquired 890 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This represents a 2.06% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the transaction, the chief executive officer owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This represents a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on NHI shares. Truist Financial reduced their price target on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research report on Friday, June 12th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. Zacks Research lowered shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Wells Fargo & Company cut their target price on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Finally, Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Five research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, National Health Investors has an average rating of “Moderate Buy” and an average price target of $83.86.

National Health Investors Stock Performance

Shares of NYSE NHI opened at $76.20 on Friday. The business’s 50-day moving average price is $74.23 and its two-hundred day moving average price is $79.61. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. National Health Investors, Inc. has a one year low of $67.94 and a one year high of $91.38. The company has a market capitalization of $3.69 billion, a P/E ratio of 24.58, a price-to-earnings-growth ratio of 3.44 and a beta of 0.51.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 4.8%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s payout ratio is currently 118.71%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.